Hebah A. N. Al-Ijel

  • Citations Per Year
Learn More
1 Department of Pharmaceutical Sciences, Faculty of Pharmacy, the University of Jordan, Amman, Jordan. 2 Department of Pharmacology and Biomedical Sciences, Faculty of Pharmacy and Medical Sciences, Petra University, Amman, Jordan. 3 Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, the University of Jordan, Amman, Jordan. 4(More)
Inducible nitric oxide synthase (iNOS) has been implicated in a variety of diseases prompting several attempts to discover and optimize new iNOS inhibitors. Accordingly, we explored the pharmacophoric space of 143 iNOS inhibitors. Subsequently, genetic algorithm and multiple linear regression analysis were employed to select an optimal combination of(More)
Statistical association between congenital autism and prenatal exposure to ritodrine (4-(2-((1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-ylamino)ethyl)phenol) as a tocolytic agent was a matter of concern. Moreover, neuronal nitric oxide momentous role in various behavioral and cognitive functions was reported. In this context, a correlation between(More)
Proteases mediate a wide variety of biological events and have a critical role in the development of many diseases. Protease detection methods can be hindered by the limitation of assay safety, sensitivity, specificity, time constraints and ease of on-site analysis. Notably, the implementation of various detection methods on biosensing platforms translates(More)
Sulphonylurea compounds have versatile activities such as antidiabetic, diuretic, herbicide, oncolytic, antimalarial, antifungal and anticancer. The present study describes the design, synthesis and in vivo testing of novel glycosylated aryl sulfonylurea compounds as antihyperglycaemic agents in streptozocine-induced diabetic mice. The rational for the(More)
UNLABELLED Neuronal Nitric Oxide synthase (nNOS) is an attractive challenging target for the treatment of various neurodegenerative disorders. To date, several structure-based studies were conducted to search novel selective nNOS inhibitors. OBJECTIVE Discovery of novel nNOS lead scaffolds through the integration of ligand-based threedimensional (3D)(More)
  • 1